We have recently shown that chemotherapy with immunogenic cell death (ICD)-inducing agents can be advantageously combined with fasting regimens or caloric restriction mimetics (CRMs) to achieve superior tumor growth control via a T cell-dependent mechanism. Here. we show that the blockade of the CD11b-dependent extravasation of myeloid cells blocks such a combination effect as well. B... https://www.marcelovicente.com/product-category/volumizer/